Portal de Periódicos da CAPES

THE ROLE OF TAMOXIFEN IN REDUCING BICALUTAMIDE‐INDUCED GYNAECOMASTIA AND BREAST PAIN

2007; Wiley; Volume: 99; Issue: 2 Linguagem: Inglês

10.1111/j.1464-410x.2006.06552.x

1464-410X

Martin Nuttall, James P. Harris, G.P.C. Dawkins,

BRCA gene mutations in cancer

BJU InternationalVolume 99, Issue 2 p. 243-244 THE ROLE OF TAMOXIFEN IN REDUCING BICALUTAMIDE-INDUCED GYNAECOMASTIA AND BREAST PAIN Martin C. Nuttall, Martin C. Nuttall Princess Royal University Hospital, Bromley Hospitals NHS Trust, Farnborough, Kent, UKSearch for more papers by this authorJames P. Harris, James P. Harris Princess Royal University Hospital, Bromley Hospitals NHS Trust, Farnborough, Kent, UKSearch for more papers by this authorGuy P.C. Dawkins, Guy P.C. Dawkins Princess Royal University Hospital, Bromley Hospitals NHS Trust, Farnborough, Kent, UKSearch for more papers by this author Martin C. Nuttall, Martin C. Nuttall Princess Royal University Hospital, Bromley Hospitals NHS Trust, Farnborough, Kent, UKSearch for more papers by this authorJames P. Harris, James P. Harris Princess Royal University Hospital, Bromley Hospitals NHS Trust, Farnborough, Kent, UKSearch for more papers by this authorGuy P.C. Dawkins, Guy P.C. Dawkins Princess Royal University Hospital, Bromley Hospitals NHS Trust, Farnborough, Kent, UKSearch for more papers by this author First published: 19 January 2007 https://doi.org/10.1111/j.1464-410X.2006.06552.xCitations: 7 Guy Dawkins, Department of Urology, Beckenham, Hospital Bromley Hospitals NHS Trust, 379 Croydon Road, Beckenham, Kent BR3 3QL, UK. e-mail: [email protected], [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. REFERENCES 1 Dobs A, Darkes MJ. Incidence and management of gynaecomastia in men treated for prostate cancer. J Urol 2005; 174: 1737– 42 2 See WA, Wirth M, McLeod DG et al. Bicalutamide as immediate therapy, either alone or as adjunct to standard care of patients with localised or locally advanced prostate cancer: first analysis of the Early Prostate Cancer Program. J Urol 2002; 168: 429– 35 3 Wirth MP, See WA, McLeod DG, Iverson P, Morris T, Carroll K; Casodex Early Prostate Cancer Trialists' Group. Bicalutamide 150mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of early prostate cancer program at median followup of 5.4 years. J Urol 2004; 172: 1865– 70 4 Widmark A, Fossa SD, Lundmo P et al. Does prophylactic breast irradiation prevent antiandrogen-induced gynaecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3. Urology 2003; 61: 145– 51 5 McLeod DG, Iversen P. Gynecomastia in patients with prostate cancer: a review of treatment options. Urology 2000; 56: 713– 20 6 Staiman VR, Lowe FC. Tamoxifen for flutamide/finasteride-induced gynecomastia. Urology, 1997; 50: 929– 33 7 Boccardo F, Rubagotti A, Battaglia M et al. Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. J Clin Oncol 2005; 23: 808– 15 8 Saltzstein D, Sieber P, Morris T, Gallo J. Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomised endocrinologic and clinical studies with tamoxifen and anastrozole. Prostate Cancer Prostatic Dis 2005; 8: 75– 83 9 Di Lorenzo G, Perdona S, De Placido S et al. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients prostate cancer: the role of tamoxifen and radiotherapy. J Urol 2005; 174: 2197– 203 10 British National Formulary. Available at: http://www.bnf.org/bnf/. Accessed August 2006 11 Ochel HJ. A proposal for the repositioning of prophylactic breast radiotherapy of prostate cancer patients. Future Oncol 2005; 1: 625– 9 Citing Literature Volume99, Issue2February 2007Pages 243-244 ReferencesRelatedInformation